Busca

Busca Avançada
 
Conheça o DECAGE
 Diretoria 
 Regimento Interno 
 Entre em Contato 
 Torne-se um Sócio 
 Trabalhos em Cardiogeriatria 
Sócios 
 Relação de Sócios 
 Últimas Notícias 
Educação Continuada 
 Agenda de Eventos 
 Eventos Realizados 
Publicações 
 Consensos / Diretrizes 
Esquina Cultural 
 Aulas à Distância 
 Superligado 
 Casos Clínicos 
Prevenção DECAGE
 Jogos Educativos 
 Teste Seu Coração 
 Qualidade de Vida 
Business Center 
 Coloque seu anúncio 
 Página Anterior
 
 

 

 Publicações

Abstract

Exercise supplementation to dipyridamole prevents hypotension, improves ECG sensitivity and increases heart to liver activity ratio on Tc- 99m sestamibi imaging.

JV Vitola, JC Brambatti, FC Caligaris, LR Lesse, PR Nogueira, AI Joaquim, M Loyo, FV Salis, EV Paiva, W Chalela, JC Meneghetti. Heart Institutes of Rio Preto and São Paulo, Brazil.

Dipyridamole can be used to evaluate patients unable to exercise adequately. Unfortunately, it has limitations, including frequent side effects, a low sensitivity of the electrocardiogram (ECG), and the increased splancnic vasodilation, leading to a high concentration of tracers in the liver, frequently creating inferior wall artifacts. There are benefits from adding exercise to dipyridamole, including a reduction of thallium in the liver. Whether this also occurs with Tc-99m sestamibi (MIBI), and to what degree, remains to be shown. This is a pertinent question considering the differences in biodistribution, elimination pathways and time interval for imaging between these 2 tracers. Exercise supplementation also increases ECG positivity, but the impact on ECG sensitivity and specificity has not been determined. The current study was designed to evaluate these effects. Ninety consecutive patients undergoing dipyridamole myocardial SPECT, using MIBI, who were limited but not completely disabled for exercise, were evaluated using our protocol of exercise supplementation (DipEx). Dipyridamole was infused over 4 minutes and exercise on the treadmill was added after the third minute. The tracer was injected always between minutes 6 and 9. The findings were compared to a control group (Dip) made of 99 patients undergoing dipyridamole infusion alone. All patients with left bundle branch block, pacemaker and atrial fibrilation were excluded. Patients tolerated well the protocol exercising 4.2 ± 1.3 minutes. Compared to Dip, patients on the DipEx group had no hypotension (6 vs 0%, p=0.03) a higher sensitivity of the ECG to detect ischemia (6% vs 34%, p=0.003), and a higher heart to liver activity ratio (1.3 ± 0.4 vs 1.6 ± 0.5, p=0.0000). The increase in ECG sensitivity on the DipEx group was associated with a significant drop in specificity compared to the Dip group (67 vs 100%, p=0.000001). In conclusion, our results show that exercise supplementation to dipyridamole results in several benefits during MIBI imaging, including a significant increase in the heart to liver activity ratio and can be used in patients who are not completely unable to exercise.

VOLTAR

© Copyright Portais SBC - Sociedade Brasileira de Cardiologia - 1996 - 2005